Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 2003

View Archived Issues

Stampidine demonstrates potent antiretroviral activity in chronically FIV-infected cats

Novel MMP and/or TNF-alpha production inhibitors under study at Fujisawa

Researchers at Akzo Nobel identify new metabolically stable androgenic agents

New Tie-2 and/or VEGFR2 kinase inhibitors prepared and tested by GSK scientists

Novel benzazepine-based CCR5 antagonists and their use in HIV infection

Several series of B-Raf kinase inhibitors discovered at GSK

Novel NK1 antagonists with utility in pain, depression, anxiety, etc.

Schering-Plough and Novartis to codevelop Asmanax/Foradil combination product

Novel CXCR4 receptor antagonist with potent and selective anti-HIV-1 activity

Glatiramer acetate slows neurological disability progression in MS

New data on the effects of SLV-306 and its potential use in congestive heart failure

Ghrelin reported to promote sleep in humans

Efficacy of parecoxib in postoperative pain following orthopedic surgery

E-5564 effective in septic shock

Good efficacy and safety profile for ziprasidone in acute bipolar mania

TA-CD enters phase IIa cocaine administration study

BresaGen demonstrates functional proof of concept for cell therapy in PD

Rebetol granted priority review for pediatric hepatitis C

Axokine promotes weight loss in phase II study

ENT-103 reviewed by expert pain panel

EG-3306 inhibits retinal neovascularization in vitro

Ribozyme concludes Medizyme joint venture with Elan

Scientists have mapped the genetic sequence of the virus believed to cause SARS

Idenix reports positive results for NM-283 and telbivudine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...